Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × HER2-positive Breast Cancer × tucatinib × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1 Approved for marketing 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 HER2-positive Breast Cancer 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pyrotinib 5 Trastuzumab 5 pertuzumab 2 tucatinib 1 neratinib 1 exemestane 1 dalpiciclib 1 Paclitaxel 1 Leuprolide 1 Goserelin 1 Fulvestrant 1 Docetaxel 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07413939 2026-03-10

BREnnA

Hoffmann-La Roche

Phase 2/3 Not yet recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡